Radikal sistektomi uygulanan hastalarda preoperatif AST/ALT (De Ritis) oranlarının prognostik önemi
Amaç: Radikal sistektomi (RC) uygulanan mesane kanseri (BC) hastalarında preoperatif olarak değerlendirilen aspartat aminotransaminaz (AST) / alanin aminotransferaz (ALT) (De Ritis) oranının prognostik önemini değerlendirmeyi amaçladık. Yöntem: Ocak 2008 ile Ağustos 2018 tarihleri arasında üçüncü basamak hastanemizde RS uygulanan 58 hastanın klinik ve histopatolojik verilerini inceledik. De Ritis oranının BC üzerindeki potansiyel prognostik değeri ROC eğrisi analizi kullanılarak değerlendirildi. Hastalığa bağlı sağ kalım (DSS) ve genel sağ kalım (OAS) da De Ritis oranının etkisi, Kaplan-Meier yöntemi ve multivariate Cox regresyon modelleri ile analiz edildi. Bulgular: RC uygulanan toplamda ellisekiz hastanın 95.6% erkek (E/K:56/2) idi. Hastaların yaş ortalaması 68.6± 11,56 idi. ROC analizine göre DSS için De Ritis oranının cut-off değeri 1.417 olarak saptandı. Kaplan-Meier analizlerinde yüksek De Ritis oran grubu DSS ve OAS'de daha kötü progresyon gösterdi (p =0.004). Klinik ve patolojik parametrelerin Cox regresyon modellerinde DSS için De Ritis oranı (HR 2.70, 95% CI 2.34-3.05 p=0.005), patolojik T evresi (HR 3.36, 95% CI 2.91-3.82, p =0.007) ve yaş (HR 1,038 95% CI 1,02-1,05; p=0.015) iken OAS için De Ritis oranı (HR 2.71, 95% CI 2.33 -3.09; p =0.005), patolojik T evresi (HR 4.36, 95% CI 3.87–4.85; p=0.007) ve yaş (HR 1.4 , 95% CI 1.03-1.06; p = 0.015) bağımsız prognostik faktörler olarak belirlendi. Sonuç: Preoperatif artmış De Ritis oranı; RC uygulanan BC hastalarında bağımsız bir prognostik faktör olarak değerlendirilebilir. Sonuçlarımızın geniş ve uygun şekilde tasarlanmış prospektif, randomize çalışmalarla doğrulanması ve desteklenmesi gerekmektedir.
Preoperative AST/ALT (De Ritis) Ratio as a Prognostic Factor in a Cohort of Patients who underwent radical cystectomy
Objective: This study aims to evaluate the prognostic significance of the preoperative aspartate aminotransferase (AST)/ alanine aminotransferase (ALT) (De Ritis) ratio in bladder cancer (BC) patients who underwent radical cystectomy(RC).Method: We evaluated the clinical and histopathological data of 58 patients who had undergone RC between January2008-August 2018 at our tertiary hospital. The potential prognostic value of the De Ritis ratio with regard to BC wasevaluated using ROC curve analysis. The effect of the De Ritis ratio on disease specific survival (DSS) and overallsurvival (OS) was analyzed using the Kaplan-Meier method and multivariate Cox regression models.Results: A total of fifty-eight patients underwent RC and 95.6% were male (M/F:56/2). Mean age of the patients was68.6± 11,56. The cut-off value of the De Ritis ratio for DSS was calculated as 1.417 in the ROC analysis. In Kaplan-Meier analyses, the group with a higher De Ritis ratio presented a more unfavorable progression in terms of DSS andOS (p=0.004). Based on the Cox regression models adjusted for clinical and pathological parameters, for DSS, the DeRitis ratio (HR 2.70, 95% CI 2.34-3.05 p=0.005), pathological T stage (HR 3.36, 95% CI 2.91-3.82, p =0.007), and age(HR 1,038 95% CI 1,02-1,05; p=0.015) were determined as independent prognostic factors; and for OS, the De Ritisratio (HR 2.71, 95% CI 2.33 -3.09; p =0.005), pathological T stage (HR 4.36, 95% CI 3.87–4.85; p=0.007) and age (HR1.04, 95% CI 1.03-1.06; p = 0.015) were determined as independent prognostic factors.Conclusions: A higher preoperative De Ritis ratio can be considered as an independent prognostic factor in BC patientswho underwent RC. Our results need to be confirmed and corroborated by comprehensive prospective randomizedstudies with an appropriate design.
___
- Ferlay J, Steliarova-Foucher E, Lortet-
Tieulent J, Rosso S, Coebergh JWW,
Comber H, et al. Cancer incidence and
mortality patterns in Europe: Estimates
for 40 countries in 2012. Eur J Cancer.
2013; 49(6):1374–403.
- Burger M, Catto JWF, Dalbagni G,
Grossman HB, Herr H, Karakiewicz P, et
al. Epidemiology and Risk Factors of
Urothelial Bladder Cancer. Eur Urol.
2013; 63(2):234–41.
- Stein JP, Lieskovsky G, Cote R, Groshen
S, Feng AC, Boyd S, et al. Radical
cystectomy in the treatment of invasive
bladder cancer: long-term results in 1,054
patients. J Clin Oncol. 2001; 19(3):666–
75.
- Jewett HJ. Proceedings: Cancer of the
bladder. Diagnosis and staging. Cancer.
1973]; 32(5):1072–4.
- ROSENBERG J, CARROLL P, SMALL
E. UPDATE ON CHEMOTHERAPY
FOR ADVANCED BLADDER
CANCER. J Urol. 2005; 174(1):14–20.
- Herr HW, Sogani PC. Does early
cystectomy improve the survival of
patients with high risk superficial bladder
tumors? J Urol. 2001; 166(4):1296–9.
- Botros M, Sikaris KA. The De Ritis
Ratio: The Test of Time. Vol. 34, Clin
Biochem Rev. 2013; 34(3):117-30
- DE RITIS F, COLTORTI M, GIUSTI G.
An enzymic test for the diagnosis of viral
hepatitis; the transaminase serum
activities. Clin Chim Acta. 1957; 2(1):70–
4.
- Thornburg JM, Nelson KK, Clem BF,
Lane AN, Arumugam S, Simmons A, et
al. Targeting aspartate aminotransferase in
breast cancer. Breast Cancer Res.
2008; 10(5):R84.
- Stocken DD, Hassan AB, Altman DG,
Billingham LJ, Bramhall SR, Johnson PJ,
et al. Modelling prognostic factors in
advanced pancreatic cancer. Br J Cancer.
2008; 99(6):883–93.
- Nishikawa M, Miyake H, Fujisawa M. De
Ritis (aspartate transaminase/alanine
transaminase) ratio as a significant
predictor of recurrence-free survival in
patients with upper urinary tract urothelial
carcinoma following nephroureterectomy.
Urol Oncol. 2016; 34(9):417.e9-417.e15.
- Bezan A, Mrsic E, Krieger D, Stojakovic T, Pummer K, Zigeuner R, et al. The
Preoperative AST/ALT (De Ritis) Ratio
Represents a Poor Prognostic Factor in a
Cohort of Patients with Nonmetastatic
Renal Cell Carcinoma. J Urol. 2015;
194(1):30–5.
- Lee H, Lee SE, Byun S-S, Kim HH,
Kwak C, Hong SK. De Ritis ratio
(aspartate transaminase/alanine
transaminase ratio) as a significant
prognostic factor after surgical treatment
in patients with clear-cell localized renal
cell carcinoma: a propensity scorematched
study. BJU Int.
2017; 119(2):261–7.
- Poon RT, Fan ST, Lo CM, Liu CL, Ng
IO, Wong J. Long-term prognosis after
resection of hepatocellular carcinoma
associated with hepatitis B-related
cirrhosis. J Clin Oncol. 2000; 18(5):1094–
101.
- Zoppini G, Cacciatori V, Negri C, Stoico
V, Lippi G, Targher G, et al. The
aspartate aminotransferase-to-alanine
aminotransferase ratio predicts all-cause
and cardiovascular mortality in patients
with type 2 diabetes. Medicine
(Baltimore). 2016 Oct; 95(43):e4821.
- O’Reilly SM, Richards MA, Rubens RD.
Liver metastases from breast cancer: the
relationship between clinical, biochemical
and pathological features and survival.
Eur J Cancer . 1990; 26(5):574–7.
- Chougule A, Hussain S, Agarwal DP.
Prognostic and diagnostic value of serum
pseudocholinesterase, serum aspartate
transaminase, and serum alinine
transaminase in malignancies treated by
radiotherapy. J Cancer Res Ther. 2008;
4(1):21–5.
- Tan X, Xiao K, Liu W, Chang S, Zhang
T, Tang H. Prognostic factors of distal
cholangiocarcinoma after curative
surgery: a series of 84 cases.
Hepatogastroenterology. 2013;
60(128):1892–5.
- Takenaka Y, Takemoto N, Yasui T,
Yamamoto Y, Uno A, Miyabe H, et al.
Transaminase Activity Predicts Survival
in Patients with Head and Neck Cancer.
Langevin SM, editor. PLoS One. 2016;
11(10):e0164057.
- Chen S-L, Li J-P, Li L-F, Zeng T, He X.
Elevated Preoperative Serum Alanine
Aminotransferase/Aspartate
Aminotransferase (ALT/AST) Ratio Is
Associated with Better Prognosis in
Patients Undergoing Curative Treatment
for Gastric Adenocarcinoma. Int J Mol
Sci. 2016; 917(6):911. doi:
10.3390/ijms17060911.
- Lee H, Choi YH, Sung HH, Han DH, Jeon
HG, Chang Jeong B, et al. De Ritis Ratio
(AST/ALT) as a Significant Prognostic
Factor in Patients With Upper Tract
Urothelial Cancer Treated With Surgery.
Clin Genitourin Cancer. 2017
Jun;15(3):e379–85.
- Wang H, Fang K, Zhang J, Jiang Y, Wang
G, Zhang H, et al. The significance of De
Ritis (aspartate transaminase/alanine
transaminase) ratio in predicting
pathological outcomes and prognosis in
localized prostate cancer patients. Int Urol
Nephrol. 2017; 49(8):1391–8.
- Tai Y-S, Chen C-H, Huang C-Y, Tai H-C,
Wang S-M, Pu Y-S. Diabetes mellitus
with poor glycemic control increases
bladder cancer recurrence risk in patients
with upper urinary tract urothelial
carcinoma. Diabetes Metab Res Rev.
2015 Mar; 31(3):307–14.
- Whyard T, Waltzer WC, Waltzer D,
Romanov V. Metabolic alterations in
bladder cancer: applications for cancer
imaging. Exp Cell Res. 2016 Feb
1;341(1):77–83.
- DeBerardinis RJ, Mancuso A, Daikhin E,
Nissim I, Yudkoff M, Wehrli S, et al.
Beyond aerobic glycolysis: transformed
cells can engage in glutamine metabolism
that exceeds the requirement for protein
and nucleotide synthesis. Proc Natl Acad
Sci USA . 2007 Dec 4;104(49):19345–50.
- Greenhouse W V, Lehninger AL.
Occurrence of the malate-aspartate shuttle
in various tumor types. Cancer Res. 1976
Apr; 36(4):1392–6.
- Fantin VR, St-Pierre J, Leder P.
Attenuation of LDH-A expression
uncovers a link between glycolysis,
mitochondrial physiology, and tumor
maintenance. Cancer Cell. 2006 Jun;
9(6):425–34.
- Gorgel SN, Kose O, Koc EM, Ates E,
Akin Y, Yilmaz Y. The prognostic significance of preoperatively assessed
AST/ALT (De Ritis) ratio on survival in
patients underwent radical cystectomy. Int
Urol Nephrol [Internet]. 2017 Sep;
49(9):1577–83.